Founded
KANDO id: 112138

Corporate information

Registration country

Company type

Whole-cell allogenic vaccines for cancer. Acquired by VaxOnco Inc.

Funding rounds

Series C


( )

Profile Country
3i Group PLC Major, long established, quoted private equity investor


Investment activity status
Active investor

Current team

Past employees

Selected Products / Customers

Financials